Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain, S Badal, BB Bajgain, MJ Santana - American journal of …, 2021 - Elsevier
Introduction On February 11, 2020 WHO designated the name “COVID-19” for the disease
caused by “severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), a novel virus …

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain, S Badal, BB Bajgain… - American journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction On February 11, 2020 WHO designated the name" COVID-19" for the disease
caused by" severe acute respiratory syndrome coronavirus 2"(SARS-CoV-2), a novel virus …

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.

KT Bajgain, S Badal, BB Bajgain… - American Journal of …, 2020 - europepmc.org
Methods A comprehensive systematic search was performed on PubMed, Medline, Scopus,
Embase, and Google Scholar to find articles published until May 15, 2020. All relevant …

Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature.

KT Bajgain, S Badal, BB Bajgain, MJ Santana - 2021 - cabidigitallibrary.org
Abstract Introduction: On February 11, 2020 WHO designated the name" COVID-19" for the
disease caused by" severe acute respiratory syndrome coronavirus 2"(SARS-CoV-2), a …

[HTML][HTML] Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain, S Badal, BB Bajgain… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Methods A comprehensive systematic search was performed on PubMed, Medline, Scopus,
Embase, and Google Scholar to find articles published until May 15, 2020. All relevant …

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain, S Badal, BB Bajgain… - American Journal of …, 2021 - ajicjournal.org
Introduction On February 11, 2020 WHO designated the name" COVID-19" for the disease
caused by" severe acute respiratory syndrome coronavirus 2"(SARS-CoV-2), a novel virus …

Prevalence of Comorbidities Among Individuals With COVID-19: A Rapid Review of current Literature

KT Bajgain, S Badal, BB Bajgain, MJ Santana - 2020 - expeditiorepositorio.utadeo.edu.co
On February 11, 2020 WHO designated the name “COVID-19” for the disease caused by
“severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), a novel virus that first …

[PDF][PDF] Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain - 2020 - researchgate.net
Methods: A comprehensive systematic search was performed on PubMed, Medline, Scopus,
Embase, and Google Scholar to find articles published until May 15, 2020. All relevant …

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain, S Badal, BB Bajgain… - American Journal of …, 2021 - ajicjournal.org
Introduction On February 11, 2020 WHO designated the name" COVID-19" for the disease
caused by" severe acute respiratory syndrome coronavirus 2"(SARS-CoV-2), a novel virus …

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain, S Badal, BB Bajgain… - American journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction On February 11, 2020 WHO designated the name" COVID-19" for the disease
caused by" severe acute respiratory syndrome coronavirus 2"(SARS-CoV-2), a novel virus …